2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer
{{output}}
Purpose: Stereotactic body radiotherapy (SBRT) with focal boost to the dominant intraprostatic lesion (DIL) provides a strategy to enhance outcomes in high-risk localised prostate cancer while minimising toxicity. This study asse... ...
